Edwards Lifesciences Corp EW

Morningstar Rating
$66.58 +0.81 (1.23%)
View Full Chart

Company Report

Price vs Fair Value

EW is trading at a 882% premium.
Price
$66.58
Fair Value
$29.00
Uncertainty
High
1-Star Price
$792.90
5-Star Price
$92.60
Economic Moat
Nqktzfc
Capital Allocation
Wssvwrmrh

Bulls Say, Bears Say

Bulls

Edwards' efforts to focus on efficiency and higher-margin products have paid off, as gross margins increased from 47% in 2000 to 77% in 2023.

Bears

Edwards' ambitions to diversify into minimally invasive medical technologies place the firm in direct competition with much larger competitors, such as Medtronic and Abbott, which can easily bid up prices for emerging technologies that Edwards couldn't match.

News

Trading Information

Previous Close Price
$65.77
Day Range
$65.8567.32
52-Week Range
$58.9396.12
Bid/Ask
$66.03 / $67.41
Market Cap
$40.11 Bil
Volume/Avg
5.2 Mil / 6.5 Mil

Key Statistics

Price/Earnings (Normalized)
25.71
Price/Sales
7.02
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.95%

Company Profile

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
19,800

Competitors

Valuation

Metric
EW
MDT
ABT
Price/Earnings (Normalized)
25.7117.0525.26
Price/Book Value
5.392.394.98
Price/Sales
7.023.624.83
Price/Cash Flow
25.6415.8118.32
Price/Earnings
EW
MDT
ABT

Financial Strength

Metric
EW
MDT
ABT
Quick Ratio
2.321.351.18
Current Ratio
3.712.131.68
Interest Coverage
7.6611.17
Quick Ratio
EW
MDT
ABT

Profitability

Metric
EW
MDT
ABT
Return on Assets (Normalized)
16.53%7.66%10.75%
Return on Equity (Normalized)
22.97%13.69%20.45%
Return on Invested Capital (Normalized)
19.92%9.84%14.91%
Return on Assets
EW
MDT
ABT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
SsyzkwnqdQcmldxy$195.6 Bil
Stryker Corp
SYK
KbvtgmmmqYcjmt$137.3 Bil
Boston Scientific Corp
BSX
NmyvbhtphJshws$122.7 Bil
Medtronic PLC
MDT
RclcdsyvGzwnlr$114.6 Bil
Koninklijke Philips NV ADR
PHG
GvkffHnw$30.7 Bil
DexCom Inc
DXCM
TwlzlmwtnKlfl$27.0 Bil
Steris PLC
STE
SvzcddhjgDpddmdj$23.6 Bil
Zimmer Biomet Holdings Inc
ZBH
HxtdmvrzdBkjn$22.0 Bil
Insulet Corp
PODD
GmsxxbpswgLvrlhq$16.3 Bil

Sponsor Center